Cameroon will start vaccinating its citizens against the COVID-19 with the British AstraZeneca vaccine on April 26.
The first consignment of 400,000 doses was received in Cameroon by the Prime Minister, Dion Ngute on Saturday, April 17 and the country is due to receive a total of 1.7 million doses of the British vaccine before the end of May 2021.
The AstraZeneca vaccine acquired under the Covax initiative is the second vaccine received by Cameroon after the Chinese Sinopharm vaccine which was received on April 12.
According to Dr Brice Edzoa Essomba, the Coordinator of the Centre Regional Technical Group for the Enlarged Programme of Vaccination, the AstraZeneca vaccine “doses shall be placed in six vaccination sites which are already operational in the Centre region for conservation.”
On April 26, the vaccine would be administered to persons classified as priority targets by the Public Health Emergency Scientific Council and the National Immunization Technical Advisory Group.
“These include persons at risk, living with comorbidity factors such as cancer, hypertension, obesity and those aged above 50 years, teachers and police agents, etc,” Essomba said.
The vaccine administration would be carried out by public health personnel who since Monday, April 19 are being trained on the best way to administer the COVID-19 vaccine. The training would last until Friday, April 23.
After the training, the public health personnel would be deployed to the vaccination centres throughout the country for the operational phase.
Support Our Journalism
There are millions of ordinary people affected by conflict in Africa whose stories are missing in the mainstream media. HumAngle is determined to tell those challenging and under-reported stories, hoping that the people impacted by these conflicts will find the safety and security they deserve.
To ensure that we continue to provide public service coverage, we have a small favour to ask you. We want you to be part of our journalistic endeavour by contributing a token to us.
Your donation will further promote a robust, free, and independent media.Donate Here